| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
InfuSystem Holdings, Inc.$9.22
+0.08 (+0.88%)
Market Cap
-
EPS
-
P/E Ratio
-
Value Trade
1.15 M
SEC Financials
Q1 2026Dilution Risk
Revenue
33.68 M
Operating CF
970.00 K
Total Assets
98.66 M
Total Liabilities
39.91 M
Equity
58.75 M
%
Week
%
1 Month
%
3 Month
%
6 Month
%
5 Year
%
All Time
Cash Data
Cash Position
2.11 M
Monthly Burn
-
Runway
-
Burn Trend
StableSEC Filing
May 8, 2026
Overview
Volume
238.25 K
52 Week Range
-
% held by Insiders
10.45 %
% held by Institutions
76.4 %
Enterprise Value
-
Total Shares
20.35 M
Short %
4.42 %
Float Shares
18.43 M
Company Description
locked
Upcoming Catalyst
Past FDA Catalysts & PDUFA Decisions
| Date | Drug | Catalyst | Stage | Outcome | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|---|
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
— | Example Drug | Phase 3 data readout | Phase 3 | — | – | 0% | 0% |
Drug Pipeline Intelligence
Clinical Trial Results
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in INFU
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
INFU Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
| 2026-09-18 | 0.00 | 0 | - | - | - | - | - | - | ||||
| 2026-09-18 | 0.00 | 0 | - | - | - | - | - | - | ||||
| 2026-09-18 | 0.00 | 0 | - | - | - | - | - | - | ||||
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
-INFU
Aug 4, 2026▲ +0.9%today
InfuSystem Announces Financial Results for Second Quarter 2026
InfuSystem has announced its financial results for the second quarter of 2026. The announcement was made from Rochester Hills, Michigan. Further details regarding the financial performance were not provided in the article.
Read more →-INFU
Jul 28, 2026▲ +6%on this news
InfuSystem to Report Second Quarter 2026 Financial Results on August 4, 2026
InfuSystem has announced that it will report its financial results for the second quarter of 2026 on August 4, 2026. This announcement is part of the company's regular financial reporting schedule. Investors and stakeholders will be able to assess the company's performance during this period once the results are disclosed.
Read more →-INFU
May 18, 2026InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 (248) 291-1210 Contact Barry Steele Chief Financial Officer (248) 260-2211 InfuSystem Announces $20 Million Stock Repurchase Program Rochester Hills
InfuSystem Holdings, Inc. has announced a new stock repurchase program, allowing for the repurchase of up to $20 million of its outstanding common stock from July 1, 2026, to June 30, 2028. This program supersedes a previous authorization set to expire soon and is intended to enhance shareholder value. CEO Carrie Lachance emphasized the company's confidence in its growth strategy and the strength of its balance sheet, while also maintaining a focus on strategic investments for sustainable growth.
Read more →-INFU
May 7, 2026▼ -11.5%on this news
InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 (248) 291-1210 Contact Barry Steele Chief Financial Officer (248) 260-2211 InfuSystem Announces Financial Results for First Quarter 2026 Net Revenue
InfuSystem Holdings, Inc. reported its financial results for the first quarter of 2026, revealing a net revenue of $33.7 million, marking a 3% decline from the previous year. While there were positive gains in Patient Services and an improvement in adjusted EBITDA margins, the Device Solutions segment experienced a significant 17% decrease in net revenue. The company reaffirmed its full-year guidance and highlighted continued growth potential in the wound care category, alongside the successful implementation of a new ERP system intended to boost operational efficiency.
Read more →-INFU
Apr 30, 2026InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 248-291-1210 FOR IMMEDIATE RELEASE CONTACT Barry Steele Chief Financial Officer 248-260-2211 InfuSystem to Report First Quarter 2026 Financial Resul
InfuSystem Holdings, Inc. has announced that it will report its first quarter 2026 financial results on May 7, 2026, before market opens. Following the release, the company will host an investor conference call at 9:00 a.m. Eastern Time to discuss these results. InfuSystem is noted as a prominent provider of healthcare services related to durable medical equipment, supporting outpatient care effectively.
Read more →-INFU
Mar 16, 2026InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 (248) 291-1210 Contact Barry Steele Chief Financial Officer (248) 260-2211 InfuSystem to Participate at 38th Annual ROTH Conference on
InfuSystem Holdings, Inc. will participate in the 38th Annual ROTH Conference on March 23, 2026, at The Ritz-Carlton Laguna Niguel, California. Company executives, including CEO Carrie Lachance and CFO Barry Steele, will host one-on-one meetings for investors. InfuSystem specializes in facilitating outpatient care within the durable medical equipment sector through its Patient Services and Device Solutions platforms, providing comprehensive support for healthcare providers.
Read more →-INFU
Feb 27, 2026q25investorpr Investor Presentation
InfuSystem's recent investor presentation highlights its ongoing growth and strategic initiatives aimed at enhancing patient care through medical equipment and services. The company has demonstrated a strong financial performance, achieving record revenues for seven consecutive years and an expected adjusted EBITDA of $31.5 million in 2025. InfuSystem's expansion into multiple therapy areas and robust partnerships with leading hospital systems across the U.S. positions it favorably within the healthcare market. The presentation also emphasizes a comprehensive approach to patient support and outcomes, contributing to its successful business model.
Read more →-INFU
Feb 24, 2026▲ +13.5%on this newsshared move
InfuSystem Announces Financial Results for Fourth Quarter and Full Year 2025
InfuSystem Holdings, Inc. reported strong financial results for 2025, marking its seventh consecutive year of record net revenues at $143.4 million, a 6% increase from the previous year. Net income surged by 183% to $6.6 million, and Adjusted EBITDA rose by 24% to $31.5 million. However, the company anticipates a revenue decrease of $7.1 million due to a restructuring of a major biomedical services contract, though it still expects overall revenue growth of 6% to 8% in 2026.
Read more →-INFU
Feb 24, 2026▲ +13.5%on this newsshared move
InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 (248) 291-1210 Contact Barry Steele Chief Financial Officer (248) 260-2211 InfuSystem Announces Financial Results for Fourth Quarter and Full Year 2
InfuSystem Holdings, Inc. reported financial results for the fourth quarter and full year 2025, showcasing continued growth and profitability. The company achieved record net revenues of $143.4 million for 2025, with a 6% increase compared to the previous year, and a substantial net income rise of 183%. Despite a decrease in net cash from operations by 10%, management remains optimistic about ongoing initiatives to enhance growth, including a new revenue cycle management platform and establishing new relationships in the healthcare sector.
Read more →-INFU
Feb 17, 2026InfuSystem to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026
InfuSystem Holdings, Inc. will announce its preliminary financial results for the fourth quarter and full year 2025 on February 24, 2026. A conference call is scheduled for the same day at 9:00 a.m. ET to discuss these results. The company operates as a healthcare service provider, focusing on outpatient care and durable medical equipment.
Read more →-INFU
Feb 17, 2026InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 248-291-1210 FOR IMMEDIATE RELEASE CONTACT Barry Steele Chief Financial Officer 248-260-2211 InfuSystem to Report Fourth Quarter and Full Year 2025
InfuSystem Holdings, Inc. announced that it will release its preliminary fourth quarter and full year 2025 financial results on February 24, 2026, prior to market opening. In conjunction with this release, the company will host a conference call at 9:00 a.m. Eastern Time to discuss the results. InfuSystem specializes in providing outpatient care service solutions for durable medical equipment manufacturers and healthcare providers.
Read more →-INFU
Dec 10, 2025InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 248-291-1210 FOR IMMEDIATE RELEASE CONTACT Barry Steele Chief Financial Officer 248-260-2211 Ambulatory Infusion Pumps used in Pain Management Busin
InfuSystem Holdings, Inc. announced that the Centers for Medicare and Medicaid Services (CMS) will provide separate payment for its electronic infusion pumps under the NOPAIN Act starting January 1, 2026. This decision recognizes the CADD-SolisTM and SapphireTM pumps as effective non-opioid options for pain management. The initiative is intended to promote safer pain management alternatives and reduce reliance on opioids. InfuSystem's CEO expressed optimism about potential growth in their Pain Management business, although concerns remain regarding reimbursement understanding and customer adoption.
Read more →-INFU
Nov 10, 2025InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 248-291-1210 FOR IMMEDIATE RELEASE CONTACT Joe Dorame, Joe Diaz Robert Blum Lytham Partners, LLC 602-889-9700 InfuSystem to Participate at 16th Annu
InfuSystem Holdings, Inc. has announced its participation in the upcoming 16th Annual Craig-Hallum Alpha Select Conference scheduled for November 18, 2025. Key executives, including President Carrie Lachance and CFO Barry Steele, will hold one-on-one meetings with investors. The company provides outpatient care services and operates under a dual platform model, addressing multiple segments of healthcare. However, they face potential risks regarding future growth and economic uncertainties.
Read more →-INFU
Nov 4, 2025▼ -9%on this news
InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 248-291-1210 CONTACT Joe Dorame, Joe Diaz Robert Blum Lytham Partners, LLC 602-889-9700 InfuSystem Reports Third Quarter 2025 Financial Results Reco
InfuSystem Holdings, Inc. reported its third quarter 2025 financial results, achieving record net revenues of $36.5 million, a 3% increase from the previous year. The company also noted a 25% rise in net income to $2.3 million. While the Patient Services segment showed significant growth, the Device Solutions segment faced a decline. Management emphasized ongoing improvements and profitable growth strategies, although recent contract restructuring may impact future revenues in biomedical services.
Read more →-INFU
Oct 28, 2025InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 248-291-1210 FOR IMMEDIATE RELEASE CONTACT Joe Dorame, Joe Diaz Robert Blum Lytham Partners, LLC 602-889-9700 InfuSystem to Report Third Quarter 202
InfuSystem Holdings, Inc. announced that it will report its third quarter financial results for 2025 on November 4, 2025, prior to market opening. An investor conference call will be held at 9 a.m. Eastern Time the same day, allowing stakeholders to discuss the financial outcomes. The call can be accessed via phone or live webcast. InfuSystem offers services under a two-platform model, focusing on outpatient care across various medical fields.
Read more →-INFU
Sep 25, 2025InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 248-291-1210 FOR IMMEDIATE RELEASE CONTACT Joe Dorame, Joe Diaz Robert Blum Lytham Partners, LLC 602-889-9700 InfuSystem to Present at 4 th Annual R
InfuSystem Holdings, Inc. has announced its participation in the 4th Annual ROTH Healthcare Opportunities Conference scheduled for October 9, 2025. The company's CEO and CFO will represent InfuSystem at the event, highlighting its role as a significant national healthcare service provider. This participation reflects the company's commitment to providing outpatient care and engaging with investors. The conference will occur at the Metropolitan Club in New York City, with opportunities for virtual meetings for interested investors.
Read more →-INFU
Aug 5, 2025InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 248-291-1210 CONTACT Joe Dorame, Joe Diaz Robert Blum Lytham Partners, LLC 602-889-9700 InfuSystem Reports Second Quarter 2025 Financial Results Rec
InfuSystem Holdings, Inc. reported robust financial results for the second quarter of 2025, with net revenues reaching $36.0 million, a 7% increase year-over-year. The company achieved a significant net income of $2.6 million, marking a 262% rise, and an adjusted EBITDA of $8.0 million, a 32% increase. However, the revenue growth outlook for the year was revised downward, reflecting anticipated challenges in specific segments. Despite this adjustment, the company reported strong cash flow and profitability improvements.
Read more →-INFU
Jul 29, 2025InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 248-291-1210 FOR IMMEDIATE RELEASE CONTACT Joe Dorame, Joe Diaz Robert Blum Lytham Partners, LLC 602-889-9700 InfuSystem to Report Second Quarter 20
InfuSystem Holdings, Inc. has announced it will report its financial results for the second quarter of 2025 on August 5, 2025, prior to market opening. A conference call will be hosted at 9:00 a.m. Eastern Time on the same day, providing an opportunity for stakeholders to discuss the results. InfuSystem is recognized for facilitating outpatient care through its dual service platforms, focusing on durable medical equipment for healthcare providers.
Read more →-INFU
May 8, 2025▲ +15.2%on this newsshared move
InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 248-291-1210 CONTACT Joe Dorame, Joe Diaz Robert Blum Lytham Partners, LLC 602-889-9700 InfuSystem Reports First Quarter 2025 Financial Results Reco
InfuSystem Holdings, Inc. reported its financial results for the first quarter of 2025, achieving record net revenues of $34.7 million, reflecting a 9% increase compared to the previous year. The company experienced a net loss of $0.3 million, an improvement from a loss of $1.1 million in the same quarter last year. Adjusted EBITDA reached $6.3 million, representing a substantial increase of 64%, and the adjusted EBITDA margin expanded to 18.2%. The company's net operating cash flow saw an impressive rise of 372%, totaling $1.8 million, indicating strong operational performance during the quarter.
Read more →-INFU
May 1, 2025InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 248-291-1210 FOR IMMEDIATE RELEASE CONTACT Joe Dorame, Joe Diaz Robert Blum Lytham Partners, LLC 602-889-9700 InfuSystem to Report First Quarter 202
InfuSystem Holdings, Inc. will report its first quarter 2025 financial results on May 8, 2025. The announcement includes a conference call scheduled for 9:00 a.m. Eastern Time on the same day. Stakeholders can access the conference call via phone or a live webcast. InfuSystem specializes in outpatient care for durable medical equipment and operates across key states in the U.S. and Ontario, Canada.
Read more →-INFU
Apr 1, 2025InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 248-291-1210 FOR IMMEDIATE RELEASE CONTACT Joe Dorame, Joe Diaz Robert Blum Lytham Partners, LLC 602-889-9700 InfuSystem Announces CEO Transition Ca
InfuSystem Holdings, Inc. announced a leadership transition with Carrie Lachance set to become the new CEO on May 19, 2025, following Richard DiIorio's departure. The company praised Lachance's proven expertise and history within the organization, indicating a smooth transition period. Additionally, InfuSystem reaffirmed its revenue growth guidance of 8-10% for the fiscal year 2025, alongside strong operational projections. DiIorio's continued advisory role is expected to support the transition, underlining the company's focus on maintaining operational stability.
Read more →-INFU
Mar 4, 2025▼ -10.9%on this news
InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 248-291-1210 CONTACT Joe Dorame, Joe Diaz Robert Blum Lytham Partners, LLC 602-889-9700 InfuSystem Announces Operational and Financial Results for F
InfuSystem Holdings, Inc. has reported its financial results for the fourth quarter and full year 2024, showcasing record revenues and strong operational improvements. Total net revenues reached $134.9 million, marking a 7% increase compared to 2023, with notable growth in both Patient Services and Device Solutions segments. The company's operating cash flow also surged, reflecting enhanced financial efficiency. However, revenue growth was slightly below projections due to delays in a new wound care initiative and a decline in biomedical services revenue.
Read more →-INFU
Feb 25, 2025InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 248-291-1210 FOR IMMEDIATE RELEASE CONTACT Joe Dorame, Joe Diaz Robert Blum Lytham Partners, LLC 602-889-9700 InfuSystem to Report Fourth Quarter an
InfuSystem Holdings, Inc. announced it will report its preliminary fourth quarter and full year 2024 financial results on March 4, 2025. The company will host a conference call at 9:00 a.m. Eastern Time to discuss these results with interested parties. InfuSystem operates as a healthcare service provider, emphasizing outpatient care solutions for durable medical equipment. Their business model includes Patient Services and Device Solutions to enhance healthcare delivery.
Read more →-INFU
Dec 4, 2024q24investorpr Investor Presentation
InfuSystem, a leading provider of medical equipment and patient services, presented its investor prospects on December 4, 2024. The company reported five consecutive years of record revenue, showcasing a compound annual growth rate (CAGR) of 12%. InfuSystem is expanding its service offerings beyond oncology into other therapeutic areas, supported by a solid balance sheet and growth initiatives. The company’s national footprint allows it to serve a significant portion of the U.S. population, further emphasizing its strategic partnerships and operational capabilities.
Read more →-INFU
Nov 22, 2024InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 248-291-1210 FOR IMMEDIATE RELEASE CONTACT Joe Dorame, Joe Diaz Robert Blum Lytham Partners, LLC 602-889-9700 InfuSystem to Present at Sidoti Small
InfuSystem Holdings, Inc. has announced that its executive team will present at the Sidoti Small Cap Conference scheduled for December 4, 2024. The presentation will take place at 10:00 a.m. Eastern Time and will be available via webcast. Additionally, the management team will hold virtual one-on-one meetings with interested investors throughout the day, further enhancing investor engagement. The company operates under a two-platform model, supporting outpatient care for durable medical equipment manufacturers and healthcare providers.
Read more →-INFU
Nov 18, 2024InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 248-291-1210 FOR IMMEDIATE RELEASE CONTACT Joe Dorame, Joe Diaz Robert Blum Lytham Partners, LLC 602-889-9700 InfuSystem Appoints Ronald Hundzinski
InfuSystem Holdings, Inc. has appointed Ronald Hundzinski as an independent director to its Board of Directors, effective November 12, 2024. Hundzinski brings extensive finance and operational experience, having served as Chairman of Gentherm, Inc., and in various leadership roles at multiple public companies. His role aims to enhance the company's oversight capabilities and support its growth amid increasing diversification in healthcare services. He will stand for election at the next Annual Shareholders meeting in May 2025.
Read more →-INFU
Nov 7, 2024▲ +5.2%on this news· ran to +36% by day 3
InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 248-291-1210 CONTACT Joe Dorame, Joe Diaz Robert Blum Lytham Partners, LLC 602-889-9700 InfuSystem Reports Third Quarter 2024 Financial Results Reco
InfuSystem Holdings, Inc. reported robust financial results for the third quarter of 2024, with record net revenues of $35.3 million, reflecting an 11% increase from the prior year. The company also achieved significant net income growth, up 162% to $1.8 million, and saw an expansion of its Adjusted EBITDA margin to 22.3%. Management highlighted increased growth in oncology and rental businesses, alongside new strategic partnerships that are expected to enhance revenue. Despite strong overall performance, rising general and administrative expenses and a decline in sales-type lease revenue could indicate challenges ahead.
Read more →-INFU
Sep 27, 2024InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 248-291-1210 FOR IMMEDIATE RELEASE CONTACT Joe Dorame, Joe Diaz Robert Blum Lytham Partners, LLC 602-889-9700 InfuSystem to Participate in Lytham Pa
InfuSystem Holdings, Inc. will participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024. The event includes a webcasted fireside chat with CEO Richard DiIorio, facilitating investor engagement. Management will also be available for one-on-one and group meetings, emphasizing the company's proactive approach to fostering investor relationships. This conference provides a platform for InfuSystem to highlight its business strategies and growth initiatives.
Read more →-INFU
Sep 11, 2024InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 248-291-1210 FOR IMMEDIATE RELEASE CONTACT Joe Dorame, Joe Diaz Robert Blum Lytham Partners, LLC 602-889-9700 InfuSystem and Sanara MedTech Inc. Ann
InfuSystem Holdings, Inc. has announced an exclusive distribution agreement with ChemoMouthpiece, LLC for its oral cryotherapy device intended to relieve patients with oral mucositis, a common side effect for cancer patients undergoing chemotherapy. This partnership, tied to their joint venture with Sanara MedTech Inc., aims to leverage InfuSystem's extensive connections with approximately 3,000 oncology centers across the U.S. The Chemo Mouthpiece has received FDA 510(k) clearance and aligns with the American Medical Association's newly issued CPT code for potential reimbursement. Sanara's $5 million investment in ChemoMouthpiece underscores their commitment to improving cancer patient care.
Read more →-INFU
Sep 4, 2024InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 248-291-1210 FOR IMMEDIATE RELEASE CONTACT Joe Dorame, Joe Diaz Robert Blum Lytham Partners, LLC 602-889-9700 InfuSystem to Participate in Lake Stre
InfuSystem Holdings, Inc. announced its participation in Lake Street Capital Markets' 8th Annual Best Ideas Growth Conference scheduled for September 12, 2024. The company's CEO Richard DiIorio and CFO Barry Steele will be present to engage with investors through one-on-one and group meetings. The conference will take place at The Yale Club in New York City, focusing on small-cap companies and institutional investors, showcasing InfuSystem's position in the healthcare market.
Read more →-INFU
Aug 8, 2024InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 248-291-1210 CONTACT Joe Dorame, Joe Diaz Robert Blum Lytham Partners, LLC 602-889-9700 InfuSystem Reports Second Quarter 2024 Financial Results Rec
InfuSystem Holdings, Inc. reported its financial results for the second quarter of 2024, achieving record net revenues of $33.7 million, which marks a 6% increase from the prior year. The company reaffirmed its full-year guidance while noting a substantial 64.8% increase in net income to $0.7 million. Significant growth was observed in the Patient Services segment, particularly in oncology and wound care, although the Device Solutions segment faced challenges with a decrease in gross profit. Overall, the company remains optimistic about sustainable long-term growth despite some declines in margin.
Read more →-INFU
Aug 6, 2024InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 248-291-1210 FOR IMMEDIATE RELEASE CONTACT Joe Dorame, Joe Diaz Robert Blum Lytham Partners, LLC 602-889-9700 InfuSystem Announces Distribution Agre
InfuSystem Holdings, Inc. has announced a three-year distribution agreement with Smith+Nephew to distribute the RENASYS EDGE negative pressure wound therapy system. This new system is designed for home-based care for patients with chronic wounds, emphasizing convenience and ease of use. InfuSystem's extensive network of health insurance providers positions it well to enhance patient access to this therapy. The CEO expressed optimism about leveraging their Patient Services platform to create new revenue opportunities through this partnership.
Read more →-INFU
May 20, 2024InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 248-291-1210 FOR IMMEDIATE RELEASE CONTACT Joe Dorame, Joe Diaz Robert Blum Lytham Partners, LLC 602-889-9700 InfuSystem Announces $20 Million Stock
InfuSystem Holdings, Inc. announced a new stock repurchase program authorizing the buyback of up to $20 million of its common stock through June 30, 2026. This action supersedes an earlier program that was nearing expiration. The CEO emphasized the program's role in enhancing shareholder value and the company's solid operational strength. InfuSystem aims to leverage this flexibility to repurchase shares opportunistically while maintaining strategic investment priorities for future growth.
Read more →-INFU
May 9, 2024InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 248-291-1210 CONTACT Joe Dorame, Joe Diaz Robert Blum Lytham Partners, LLC 602-889-9700 InfuSystem Reports First Quarter 2024 Financial Results Reco
InfuSystem Holdings, Inc. reported its financial results for the first quarter of 2024, revealing record net revenues of $32.0 million, a 5% increase from the prior year. While gross profit rose by 10%, the company also reported a net loss of $1.1 million, a decline from last year's lesser loss. The Device Solutions segment performed well with revenue growth of 16%, offsetting a minor decline in the Patient Services segment. Management expressed confidence in continued growth despite rising G&A expenses and challenges in third-party payer collections.
Read more →-INFU
Apr 3, 2024InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 248-291-1210 FOR IMMEDIATE RELEASE CONTACT Joe Dorame, Joe Diaz Robert Blum Lytham Partners, LLC 602-889-9700 InfuSystem Receives Notice from NYSE A
InfuSystem Holdings, Inc. has received a notification from NYSE American concerning its failure to file the Annual Report on Form 10-K for the fiscal year ended December 31, 2023, by the deadline of April 1, 2024. The company cited the need for additional time to address potential errors related to expense classification and the application of new accounting standards. InfuSystem has a six-month initial cure period to resolve this issue, although continuation of its stock listing depends on compliance with filing standards.
Read more →-INFU
Mar 8, 2024▲ +5.8%on this news
COOPERATION AGREEMENT This Cooperation Agreement (this "Agreement") is made as of
A cooperation agreement has been established between InfuSystem Holdings, Inc., R. Rimmy Malhotra, and Nicoya Capital LLC. This agreement facilitates Malhotra's resignation from the Board after an 18-month tenure while promoting ongoing constructive dialogue among the parties. Specific terms include limitations on future stock acquisitions and a commitment to vote in alignment with the Board. Additionally, the agreement includes indemnity provisions to protect both the Company and Malhotra.
Read more →-INFU
Nov 28, 2023InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 248-291-1210 FOR IMMEDIATE RELEASE CONTACT Joe Dorame, Joe Diaz Robert Blum Lytham Partners, LLC 602-889-9700 InfuSystem to Present at Sidoti Small-
InfuSystem Holdings, Inc. announced that it will present at the Sidoti Small-Cap Virtual Investor Conference on December 6, 2023. The event will feature key presentations from top executives including the CEO, CFO, and COO, indicating a focus on investor relations. A webcast of the presentation will be available on their website, with opportunities for virtual one-on-one meetings for interested investors. This engagement reflects the company's commitment to transparency and investor communication.
Read more →-INFU
Nov 9, 2023q23investorpr Investor Presentation
InfuSystem has recently presented its investor update, emphasizing its focus on delivering solutions that enhance patient care while reducing costs. The company highlighted a strong financial performance with a 7% year-over-year revenue increase and a robust cash flow that supports growth initiatives. Strategic plans include expanding patient services and maintaining a competitive edge in medical equipment and device solutions. InfuSystem's market presence spans all major insurance networks, making it a key provider in outpatient care across the U.S. and Canada.
Read more →-INFU
Nov 9, 2023InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 248-291-1210 FOR IMMEDIATE RELEASE CONTACT Joe Dorame, Joe Diaz Robert Blum Lytham Partners, LLC 602-889-9700 InfuSystem to Participate at 14th Annu
InfuSystem Holdings, Inc. announced its participation in the 14th Annual Craig-Hallum Alpha Select Conference scheduled for November 16, 2023. CEO Richard DiIorio, CFO Barry Steele, and COO Carrie Lachance will represent the company at the event in New York City. The management team is also set to conduct one-on-one virtual meetings with interested investors. InfuSystem is recognized as a leading provider of healthcare services for durable medical equipment, supporting outpatient care.
Read more →-INFU
Nov 7, 2023InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 248-291-1210 CONTACT Joe Dorame, Joe Diaz Robert Blum Lytham Partners, LLC 602-889-9700 InfuSystem Reports Third Quarter 2023 Financial Results Reco
InfuSystem Holdings, Inc. has reported strong financial results for the third quarter of 2023, with net revenues reaching $31.9 million, marking a 17% increase from the previous year. Operating income rose by 80% and net income by 56%, while the company raised its full-year net revenue guidance to above 11%. However, the gross margin saw a decrease of 8.5%, and the company anticipates a dip in fourth-quarter revenues due to fewer device leases. Additionally, increased expenses related to operational scaling were noted.
Read more →-INFU
Aug 3, 2023InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 248-291-1210 CONTACT Joe Dorame, Joe Diaz Robert Blum Lytham Partners, LLC 602-889-9700 InfuSystem Reports Second Quarter 2023 Financial Results Rec
InfuSystem Holdings, Inc. reported robust second-quarter financial results, achieving record net revenues of $31.7 million, a 17% increase from the previous year. The Patient Services and Device Solutions segments both contributed positively, with notable growth in the latter. Despite these revenue gains, the company faced challenges, including a decreased gross margin and increased costs associated with onboarding for new services. Management is optimistic, projecting revenue growth to surpass earlier estimates and signaling a committed long-term growth strategy.
Read more →-INFU
Jun 21, 2023InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 248-291-1210 FOR IMMEDIATE RELEASE CONTACT Joe Dorame, Joe Diaz Robert Blum Lytham Partners, LLC 602-889-9700 InfuSystem Set to Join Russell 3000 In
InfuSystem Holdings, Inc. has announced its inclusion in the Russell 3000 Index, effective June 26, 2023. This inclusion recognizes the company's stature among the 4,000 largest U.S. stocks and is expected to increase its visibility to institutional investors. InfuSystem aims to leverage this opportunity for continued growth and value creation for its shareholders. The Russell indexes serve as important benchmarks for investment strategies, demonstrating the significance of this development for the company.
Read more →-INFU
May 5, 2023▲ +6.7%on this news
InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 248-291-1210 FOR IMMEDIATE RELEASE CONTACT Joe Dorame, Joe Diaz Robert Blum Lytham Partners, LLC 602-889-9700 InfuSystem to Present at Sidoti Micro-
InfuSystem Holdings, Inc. announced its participation in the Sidoti Micro-Cap Virtual Investor Conference on May 11, 2023. The presentation will feature key leaders from the company, including the CEO and CFO. A webcast of the event will be accessible on the company's website, providing an opportunity for investors to engage further through one-on-one meetings. This event aims to highlight the company's services and growth initiatives to potential investors.
Read more →-INFU
Nov 10, 2022▼ -5.2%on this news
InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 248-291-1210 FOR IMMEDIATE RELEASE CONTACT Joe Dorame, Joe Diaz Robert Blum Lytham Partners, LLC 602-889-9700 InfuSystem to Participate at 13th Annu
CONTACT Joe Dorame, Joe Diaz Robert Blum Lytham Partners, LLC InfuSystem to Participate at 13th Annual Craig-Hallum Alpha Select Conference on November 17, 2022 Rochester Hills, Michigan, November 10, 2022 - InfuSystem Holdings, Inc. (NYSE American INFU) ("InfuSystem" or the "
Read more →-INFU
Nov 8, 2022InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 248-291-1210 CONTACT Joe Dorame, Joe Diaz Robert Blum Lytham Partners, LLC 602-889-9700 InfuSystem Reports Third Quarter 2022 Financial Results Reco
InfuSystem Reports Third Quarter 2022 Financial Results Record Net Revenues of $27.3 million and Record ITS revenues of $17.4 million Operating Income increased $1.3 million and Net Income increased $0.9 million Rochester Hills, Michigan, November 8, 2022 - InfuSystem Holdings
Read more →-INFU
Nov 3, 2022q22investorpr Investor Presentation NOVEMBER 8, 2022 l (NYSE American: INFU) Enabling Continuity of Care for Patients, From the Clinic to Their Home Forward-Looking Statements / Non-GAAP Measures Forward-Looking Statemen
Investor Presentation NOVEMBER 8, 2022 l (NYSE American: INFU) Enabling Continuity of Care for Patients, From the Clinic to Their Home Forward-Looking Statements / Non-GAAP Measures Forward-Looking Statements Certain statements contained in this presentation are forward-looking
Read more →-INFU
Nov 3, 2022InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 248-291-1210 FOR IMMEDIATE RELEASE CONTACT Joe Dorame, Joe Diaz Robert Blum Lytham Partners, LLC 602-889-9700 InfuSystem and Sanara MedTech Announce
CONTACT Joe Dorame, Joe Diaz Robert Blum Lytham Partners, LLC InfuSystem and Sanara MedTech Announce Wound Therapy Partnership Rochester Hills, Michigan, November 3, 2022 - InfuSystem Holdings, Inc. (NYSE American INFU) ("InfuSystem" or the "Company") and Sanara MedTech Inc. (
Read more →-INFU
Sep 23, 2022InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 248-291-1210 FOR IMMEDIATE RELEASE CONTACT Joe Dorame, Joe Diaz Robert Blum Lytham Partners, LLC 602-889-9700 InfuSystem Appoints R. Rimmy Malhotra
CONTACT Joe Dorame, Joe Diaz Robert Blum Lytham Partners, LLC InfuSystem Appoints R. Rimmy Malhotra to the Board of Directors Rochester Hills, Michigan, September 23, 2022 - InfuSystem Holdings, Inc. (NYSE American INFU) ("InfuSystem" or the "Company"), a leading national heal
Read more →-INFU
Sep 8, 2022q22investorpr Investor Presentation SEPTEMBER 8, 2022 l (NYSE American: INFU) Enabling Continuity of Care for Patients, From the Clinic to Their Home Forward-Looking Statements / Non-GAAP Measures Forward-Looking Stateme
Investor Presentation SEPTEMBER 8, 2022 l (NYSE American: INFU) Enabling Continuity of Care for Patients, From the Clinic to Their Home Forward-Looking Statements / Non-GAAP Measures Forward-Looking Statements Certain statements contained in this presentation are forward-looking
Read more →-INFU
Aug 4, 2022▼ -19.3%on this news
InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 248-291-1210 CONTACT Joe Dorame, Joe Diaz Robert Blum Lytham Partners, LLC 602-889-9700 InfuSystem Reports Second Quarter 2022 Financial Results Net
InfuSystem Reports Second Quarter 2022 Financial Results Net Revenues increased 9% to $27 million ITS revenues increased 6% and DME revenues increased 15% Rochester Hills, Michigan, August 4, 2022 - InfuSystem Holdings, Inc. (NYSE American INFU), ("InfuSystem" or the "Company")
Read more →-INFU
Jun 14, 2022InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 248-291-1210 FOR IMMEDIATE RELEASE CONTACT Joe Dorame, Joe Diaz Robert Blum Lytham Partners, LLC 602-889-9700 InfuSystem and Ventis Pharma Announce
CONTACT Joe Dorame, Joe Diaz Robert Blum Lytham Partners, LLC InfuSystem and Ventis Pharma Announce National Sales and Marketing Agreement for Pain Management The Company will offer Ventis Pharma's patented local anesthetic compound, Endura-KitTM for post-operative surgical an
Read more →-INFU
May 26, 2022▲ +7.1%on this news
InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 248-291-1210 FOR IMMEDIATE RELEASE CONTACT Joe Dorame, Joe Diaz Robert Blum Lytham Partners, LLC 602-889-9700 InfuSystem to Participate at Craig-Hal
CONTACT Joe Dorame, Joe Diaz Robert Blum Lytham Partners, LLC InfuSystem to Participate at Craig-Hallum 19th Annual Institutional Investor Conference on Wednesday, June 1, 2022 Rochester Hills, Michigan, May 26, 2022 - InfuSystem Holdings, Inc. (NYSE American INFU) ("InfuSyste
Read more →-INFU
May 5, 2022▲ +14.9%on this news
InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 248-291-1210 CONTACT Joe Dorame, Joe Diaz Robert Blum Lytham Partners, LLC 602-889-9700 InfuSystem Reports First Quarter 2022 Financial Results Sign
InfuSystem Reports First Quarter 2022 Financial Results Signed 3-year Master Service Agreement with Leading Global Medical Technology and Diagnostic Company - Estimated Potential Annual Revenue of $10 Million to $12 Million Revenue Growth of 9% - Driven by 18% Growth in DME and
Read more →-INFU
Apr 28, 2022InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 248-291-1210 FOR IMMEDIATE RELEASE CONTACT Joe Dorame, Joe Diaz Robert Blum Lytham Partners, LLC 602-889-9700 InfuSystem Announces Master Service Ag
CONTACT Joe Dorame, Joe Diaz Robert Blum Lytham Partners, LLC InfuSystem Announces Master Service Agreement with Leading Global Healthcare Technology and Diagnostic Company Preferred National Service Agreement to provide service and repair to fleet of more than 300,000 pumps i
Read more →-INFU
Mar 23, 2022q21investorpr Investor Presentation
Investor Presentation March 23, 2022 l (NYSE American: INFU) Enabling Continuity of Care for Patients, From the Clinic to Their Home Forward-Looking Statements / Non-GAAP Measures Forward-Looking Statements Certain statements contained in this presentation are forward-looking st
Read more →-INFU
Feb 22, 2022InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 248-291-1210 FOR IMMEDIATE RELEASE CONTACT Joe Dorame, Joe Diaz Robert Blum Lytham Partners, LLC 602-889-9700 InfuSystem Announces Agreement with So
CONTACT Joe Dorame, Joe Diaz Robert Blum Lytham Partners, LLC InfuSystem Announces Agreement with Solo-Dex for Continuous Peripheral Nerve Block Catheters Rochester Hills, Michigan, February 22, 2022 - InfuSystem Holdings, Inc. (NYSE American INFU), ("InfuSystem" or the "Compa
Read more →-INFU
Feb 10, 2022▼ -26.5%on this news
InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 248-291-1210 CONTACT Joe Dorame, Joe Diaz Robert Blum Lytham Partners, LLC 602-889-9700 InfuSystem Announces Preliminary Operational and Financial R
InfuSystem Announces Preliminary Operational and Financial Results for Fourth Quarter and Full Year 2021 Full Year 2021 vs. Full Year 2020 Net Revenues $102.4 million, a 5% increase Net Income $1.4 million, Adjusted EBITDA $24.0 million Rochester Hills, Michigan, February 10
Read more →-INFU
Jan 13, 2022InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 248-291-1210 FOR IMMEDIATE RELEASE CONTACT Joe Dorame, Joe Diaz Robert Blum Lytham Partners, LLC 602-889-9700 InfuSystem to Present at Sidoti Winter
CONTACT Joe Dorame, Joe Diaz Robert Blum Lytham Partners, LLC InfuSystem to Present at Sidoti Winter Virtual Investor Conference on Wednesday, January 19, 2022 Investor Presentation to be held at 8 30 a.m. Eastern Time Rochester Hills, Michigan, January 13, 2022 - InfuSystem
Read more →-INFU
Nov 15, 2021▲ +11.9%on this news
InfuSystem Holdings, Inc. 3851 W. Hamlin Road Rochester Hills, MI 48309 248-291-1210 CONTACT Joe Dorame, Joe Diaz Robert Blum Lytham Partners, LLC 602-889-9700 InfuSystem Reports Third Quarter 2021 Financial Results Sele
InfuSystem Reports Third Quarter 2021 Financial Results Selected as Supplier of Infusion Pump Biomedical Services for Leading Global Medical Technology and Diagnostic Equipment Company Worth Expected $14 Million to $15 Million in Annual Revenue Potential Received Pain Managemen
Read more →-INFU
Nov 10, 2021q21investorpr Investor Presentation NOVEMBER 15, 2021 l (NYSE American: INFU) Enabling Continuity of Care for Patients, From the Clinic to Their Home Forward-Looking Statements / Non-GAAP Measures Forward-Looking Stateme
Investor Presentation NOVEMBER 15, 2021 l (NYSE American: INFU) Enabling Continuity of Care for Patients, From the Clinic to Their Home Forward-Looking Statements / Non-GAAP Measures Forward-Looking Statements Certain statements contained in this presentation are forward-looking
Read more →-INFU
Feb 7, 2018InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, MI 48071 248-291-1210 CONTACT: Joe Dorame, Joe Diaz & Robert Blum Lytham Partners, LLC 602-889-9700 InfuSystem Holdings, Inc. Reports Interim Chief Fin
InfuSystem Holdings, Inc. Reports Interim Chief Financial Officer Will Leave Company at End of Current Quarter MADISON HEIGHTS, MICHIGAN, February 7, 2018 InfuSystem Holdings, Inc. (NYSE American: INFU) ( InfuSystem or the Company ), a leading national provider of infusion pump
Read more →-INFU
Jan 31, 2018InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, MI 48071 248-291-1210 CONTACT: Joe Dorame, Joe Diaz & Robert Blum Lytham Partners, LLC 602-889-9700 InfuSystem Holdings, Inc. Announces Dismissal of Cl
InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, MI 48071 Lytham Partners, LLC InfuSystem Holdings, Inc. Announces Dismissal of Class Action Shareholder Lawsuit HEIGHTS, MICHIGAN, January 31, 2018 InfuSystem Holdings, Inc. (NYSE American: INFU) ( InfuSys
Read more →-INFU
Nov 16, 2017InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, MI 48071 248-291-1210 Richard DiIorio Appointed as President and Chief Executive Officer of InfuSystem Holdings, Inc.
Richard DiIorio Appointed as President and Chief Executive Officer of InfuSystem Holdings, Inc. MADISON HEIGHTS, MICHIGAN, November 16, 2017 InfuSystem Holdings, Inc. (NYSE American: INFU) ( InfuSystem or the Company ), a leading provider of infusion pumps and related services
Read more →-INFU
Nov 10, 2017InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, MI 48071 248-291-1210 CONTACT: Joe Dorame, Joe Diaz & Robert Blum Lytham Partners, LLC 602-889-9700 InfuSystem Holdings, Inc. Reports Third Quarter 201
Lytham Partners, LLC InfuSystem Holdings, Inc. Reports Third Quarter 2017 Financial Results AEBITDA increased 13%, compared to the third quarter of 2016 and 26%, compared to the second quarter of 2017 The Company reduced net debt by $2.9 million during the quarter and $4.7 m
Read more →-INFU
Oct 31, 2017InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, Michigan 48071 248-291-1210 FOR IMMEDIATE RELEASE CONTACT: Joe Dorame, Joe Diaz & Robert Blum Lytham Partners, LLC 602-889-9700 INFUSYSTEM TO ISSUE THI
INFUSYSTEM TO ISSUE THIRD QUARTER 2017 FINANCIAL RESULTS ON FRIDAY, NOVEMBER 10, 2017, BEFORE THE MARKET OPENS Investor Conference Call to be Held at 11:00 a.m. Eastern Time on Friday, November 10, 2017 MADISON HEIGHTS, MI, October 31, 2017 InfuSystem Holdings, Inc. (NYSE Amer
Read more →-INFU
Aug 9, 2017InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, MI 48071 248-291-1210 CONTACT: Joe Dorame, Joe Diaz & Robert Blum Lytham Partners, LLC 602-889-9700 InfuSystem Holdings, Inc. Reports Second Quarter 20
CONTACT: Joe Dorame, Joe Diaz & Robert Blum Lytham Partners, LLC 602-889-9700 InfuSystem Holdings, Inc. Reports Second Quarter 2017 Financial Results The Company reduced net debt by $2.9 million during the quarter; AEBITDA increased 113% compared to the first quarter of
Read more →-INFU
Aug 4, 2017InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, Michigan 48071 248-291-1210 FOR IMMEDIATE RELEASE CONTACT: Joe Dorame, Joe Diaz & Robert Blum Lytham Partners, LLC 602-889-9700 INFUSYSTEM TO ISSUE SEC
InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, Michigan 48071 248-291-1210 CONTACT: Joe Dorame, Joe Diaz & Robert Blum Lytham Partners, LLC 602-889-9700 INFUSYSTEM TO ISSUE SECOND QUARTER 2017 FINANCIAL RESULTS ON WEDNESDAY, AUGUST 9,
Read more →-INFU
Jun 29, 2017InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, MI 48071 248-291-1210 InfuSystem Announces Amendment to Existing Credit Facility with JPMorgan Chase
InfuSystem Announces Amendment to Existing Credit Facility with MICHIGAN, June 29, 2017 InfuSystem Holdings, Inc. (NYSE MKT: INFU) ( InfuSystem or the Company ), a leading national provider of infusion pumps and related services for the healthcare industry in the United States
Read more →-INFU
Jun 22, 2017InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, MI 48071 248-291-1210 InfuSystem Announces the Election of Darrell Montgomery and Christopher Sansone to Board of Directors
31700 Research Park Drive Madison Heights, MI 48071 InfuSystem Announces the Election of Darrell and Christopher Sansone to Board of Directors MADISON HEIGHTS, MICHIGAN, June 22, 2017 InfuSystem Holdings, Inc. (NYSE MKT: INFU) ( InfuSystem or the Company ), a leading nationa
Read more →-INFU
Jun 19, 2017InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, MI 48071 248-291-1210 INFUSYSTEM S BOARD OF DIRECTORS REJECTS 22NW FUND S
InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, MI 48071 248-291-1210 INFUSYSTEM S BOARD OF DIRECTORS REJECTS 22NW FUND S UNSOLICITED PROPOSAL AS INADEQUATE MADISON HEIGHTS, MICHIGAN, June 19, 2017 InfuSystem Holdings, Inc. (NYSE MKT: INFU) ( InfuSystem or
Read more →-INFU
May 18, 2017InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, MI 48071 248-291-1210 INFUSYSTEM HOLDINGS
INFUSYSTEM HOLDINGS, INC. ANNOUNCES EXECUTIVE MANAGEMENT CHANGES MADISON HEIGHTS, MICHIGAN, May 18, 2017 InfuSystem Holdings, Inc. (NYSE MKT: INFU) ( InfuSystem or the Company ), a leading national provider of infusion pumps and related services for the healthcare industry in t
Read more →-INFU
May 11, 2017InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, MI 48071 248-291-1210 CONTACT: Joe Dorame, Joe Diaz & Robert Blum Lytham Partners, LLC 602-889-9700 INFUSYSTEM HOLDINGS, INC. REPORTS FIRST QUARTER 201
InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, MI 48071 248-291-1210 CONTACT: Joe Dorame, Joe Diaz & Robert Blum Lytham Partners, LLC 602-889-9700 INFUSYSTEM HOLDINGS, INC. REPORTS FIRST QUARTER 2017 FINANCIAL RESULTS MADISON HEIGHTS, MICHIGA
Read more →-INFU
Apr 14, 2017InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, Michigan 48071 248-291-1210
CONTACT: Joe Dorame, Joe Diaz & Robert Blum Lytham Partners, LLC 602-889-9700 INFUSYSTEM HOLDINGS, INC. ANNOUNCES DATE OF 2017 ANNUAL MEETING OF STOCKHOLDERS MADISON HEIGHTS, MICHIGAN, April 14, 2017 InfuSystem Holdings, Inc. (NYSE MKT: INFU) ( InfuSystem or the Company
Read more →-INFU
Mar 22, 2017InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, MI 48071 248-291-1210 Wednesday
Wednesday, March 22, 2017 CONTACT: Joe Dorame, Joe Diaz & Robert Blum Lytham Partners, LLC INFUSYSTEM HOLDINGS, INC. REPORTS FOURTH QUARTER AND YEAR END 2016 FINANCIAL RESULTS MADISON HEIGHTS, MICHIGAN, March 22, 2017 InfuSystem Holdings, Inc. (NYSE MKT: INFU), a leading nati
Read more →-INFU
Mar 17, 2017InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, Michigan 48071 248-291-1210 FOR IMMEDIATE RELEASE CONTACT: Joe Dorame, Joe Diaz & Robert Blum Lytham Partners, LLC 602-889-9700 INFUSYSTEM TO ISSUE FOU
InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, Michigan 48071 248-291-1210 CONTACT: Joe Dorame, Joe Diaz & Robert Blum Lytham Partners, LLC 602-889-9700 INFUSYSTEM TO ISSUE FOURTH QUARTER AND YEAR END 2016 FINANCIAL RESULTS ON WEDNESDAY, MARC
Read more →-INFU
Dec 13, 2016InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, MI 48071 248-291-1210 CONTACT: Joe Dorame, Joe Diaz & Robert Blum Lytham Partners, LLC 602-889-9700 INFUSYSTEM HOLDINGS, INC. REPORTS THIRD QUARTER 201
CONTACT: Joe Dorame, Joe Diaz & Robert Blum Lytham Partners, LLC 602-889-9700 INFUSYSTEM HOLDINGS, INC. REPORTS THIRD QUARTER 2016 FINANCIAL RESULTS Company Announces Filing of Restated Financial Statements in Amended Annual and Quarterly Reports Filed with the SEC Inve
Read more →-INFU
Nov 28, 2016InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, MI 48071 248-291-1210 Monday
Monday, November 28, 2016 INFUSYSTEM HOLDINGS, INC. ANNOUNCES NOTIFICATION OF NONCOMPLIANCE WITH NYSE MKT CONTINUED LISTING STANDARDS MADISON HEIGHTS, MICHIGAN, November 28, 2016 InfuSystem Holdings, Inc. (NYSE MKT: INFU) (the Company ), a leading national provider of infusion
Read more →-INFU
Sep 26, 2016Safe Harbor Statement INNOVATION | TEAMWORK | INTEGRITY | FOCUS | PEOPLE FIRST Certain statements contained in this presentation are forward-looking statements and are based on future expectations, plans and prospects fo
CORPORATE PRESENTATION SEPTEMBER 2016 (NYSE MKT: INFU) Exhibit 99.1 Safe Harbor Statement INNOVATION | TEAMWORK | INTEGRITY | FOCUS | PEOPLE FIRST Certain statements contained in this presentation are forward-looking statements and are based on future expectations, plans and p
Read more →-INFU
Aug 10, 2016InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, MI 48071 248-291-1210 CONTACT: Joe Dorame, Joe Diaz & Robert Blum Lytham Partners, LLC 602-889-9700 INFUSYSTEM HOLDINGS, INC. REPORTS SECOND QUARTER 20
InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, MI 48071 248-291-1210 CONTACT: Joe Dorame, Joe Diaz & Robert Blum Lytham Partners, LLC 602-889-9700 INFUSYSTEM HOLDINGS, INC. REPORTS SECOND QUARTER 2016 FINANCIAL RESULTS Second Quarter 20
Read more →-INFU
Jul 29, 2016InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, MI 48071 248-291-1210 CONTACT: Joe Dorame, Joe Diaz & Robert Blum Lytham Partners, LLC 602-889-9700 INFUSYSTEM HOLDINGS
InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, MI 48071 248-291-1210 CONTACT: Joe Dorame, Joe Diaz & Robert Blum Lytham Partners, LLC 602-889-9700 INFUSYSTEM HOLDINGS, INC. ANNOUNCES RESIGNATION OF CHIEF FINANCIAL OFFICER AND REPLACEMENTS MA
Read more →-INFU
Feb 2, 2016Safe Harbor Statement 2 INNOVATION | TEAMWORK | INTEGRITY | FOCUS | PEOPLE FIRST Certain statements contained in this presentation are forward looking statements and are based on future expectations, plans and prospects
For this reason, we focus on annual free cash flow. ** Management estimate based on pumps retired and an assumed average replacement cost per period. Unaudited, in US$ thousands FY2011 FY2012 FY2013 FY2014 Net Income (45,443) (1,489) 1,669 3,356 plus Interest 2,193 3,340 3,497 3,
Read more →-INFU
Nov 12, 2015InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, MI 48071 CONTACT: Joe Dorame, Joe Diaz & Robert Blum 248-291-1210 Lytham Partners, LLC 602-889-9700 INFUSYSTEM HOLDINGS, INC. REPORTS THIRD QUARTER 201
InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, MI 48071 CONTACT: Joe Dorame, Joe Diaz & Robert Blum 248-291-1210 Lytham Partners, LLC 602-889-9700 INFUSYSTEM HOLDINGS, INC. REPORTS THIRD QUARTER 2015 FINANCIAL RESULTS Third Q
Read more →-INFU
May 15, 2015InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, MI 48071 248-291-1210 CONTACT: Joe Dorame, Joe Diaz & Robert Blum Lytham Partners, LLC 602-889-9700 INFUSYSTEM ANNOUNCES GREGG LEHMAN ELECTED CHAIRMAN
Joe Dorame, Joe Diaz & Robert Blum Lytham Partners, LLC ANNOUNCES GREGG LEHMAN ELECTED CHAIRMAN OF THE BOARD OF DIRECTORS Madison Heights, MI, May 15, 2015 InfuSystem Holdings, Inc. (NYSE MKT: INFU), a leading national provider of infusion pumps and related services for the
Read more →-INFU
May 12, 2015InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, MI 48071 FOR IMMEDIATE RELEASE 248-291-1210 Tuesday
InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, MI 48071 FOR IMMEDIATE RELEASE 248-291-1210 Tuesday, May 12, 2015 CONTACT: Joe Dorame, Joe Diaz & Robert Blum Lytham Partners, LLC 602-889-9700 INFUSYSTEM HOLDINGS, INC. REPORTS FIRST QUARTER 201
Read more →-INFU
May 5, 2015InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, Michigan 48071 248-291-1210 FOR IMMEDIATE RELEASE Tuesday
InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, Michigan 48071 248-291-1210 Tuesday, May 5, 2015 INFUSYSTEM HOLDINGS, INC. TO ISSUE FIRST QUARTER FINANCIAL RESULTS ON TUESDAY, Investor Conference Call to be Held at 4:30 p.m. Eastern Time MADISON HEIG
Read more →-INFU
Apr 21, 2015InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, MI 48071 248-291-1210 CONTACT: Joe Dorame, Joe Diaz & Robert Blum Lytham Partners, LLC 602-889-9700 INFUSYSTEM ANNOUNCES ACQUISITION OF CISCURA S INFUS
Joe Dorame, Joe Diaz & Robert Blum Lytham Partners, LLC ANNOUNCES ACQUISITION OF CISCURA S INFUSION PUMP FLEET InfuSystem Opens a New Southeastern Service Center Madison Heights, MI, April 21, 2015 InfuSystem Holdings, Inc. (NYSE MKT: INFU), a leading national provider of in
Read more →-INFU
Apr 15, 2015InfuSystem Holdings, Inc. Shareholder Presentation As of
Holdings, Inc. Shareholder Presentation As of April 15, 2015 Eric Steen CEO Jonathan Foster CFO Harbor Statement Certain statements contained in this presentation are forward?looking statements and are based on future expectations, plans and prospects for the business and operat
Read more →-INFU
Mar 26, 2015InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, MI 48071 248-291-1210 CONTACT: Joe Dorame, Joe Diaz & Robert Blum Lytham Partners, LLC 602-889-9700 InfuSystem Announces New $45 Million Credit Facilit
InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, MI 48071 248-291-1210 Joe Dorame, Joe Diaz & Robert Blum Lytham Partners, LLC Announces New $45 Million Credit Facility At Substantially Lower Rates Madison Heights, MI, March 26, 2015 InfuSystem Holdi
Read more →-INFU
Mar 4, 2015InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, Michigan 48071 248-291-1210 FOR IMMEDIATE RELEASE Wednesday
Wednesday, March 4, 2015 CONTACT: Joe Dorame, Joe Diaz & Robert Blum Lytham Partners, LLC 602-889-9700 INFUSYSTEM HOLDINGS, INC. TO ISSUE FOURTH QUARTER AND FULL YEAR 2014 FINANCIAL RESULTS ON MONDAY, MARCH 9, 2015 Investor Conference Call to be Held at 4:30 p.m. Eastern
Read more →-INFU
Jan 6, 2015InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, MI 48071 248-291-1210 FOR IMMEDIATE RELEASE CONTACT: Rob Swadosh The Dilenschneider Group 212-922-0900 INFUSYSTEM HOLDINGS, INC. TO PARTICIPATE IN SIDO
CONTACT: Rob Swadosh The Dilenschneider Group 212-922-0900 INFUSYSTEM HOLDINGS, INC. TO PARTICIPATE IN SIDOTI EMERGING GROWTH INSTITUTIONAL INVESTOR FORUM MICHIGAN, January 6, 2015 InfuSystem Holdings, Inc. (NYSE MKT: INFU) ( InfuSystem or the Company ), a leading nationa
Read more →-INFU
Dec 2, 2014Safe Harbor Statement Certain statements contained in this presentation are forward looking statements and are based on future expectations, plans and prospects for the business and operations of InfuSystem Holdings, Inc
Impairment charges) 11,199 $ 7,745 $ 10,256 $ 9,590 $ 14,230 $ 9,747 $ 11,054 $ Adjusted EBITDA N/A N/A 10,256 $ 13,126 $ 15,954 $ 11,271 $ 11,471 $ Detailed Historical BS (000's) 12/31/09 12/31/10 12/31/11 12/31/12 12/31/13 6/30/14 9/30/14 ASSETS Current Assets: Cash and cash eq
Read more →-INFU
Nov 10, 2014InfuSystem Holdings, Inc. FOR IMMEDIATE RELEASE Monday
InfuSystem Holdings, Inc. FOR IMMEDIATE RELEASE Monday, November 10, 2014 31700 Research Park Drive Madison Heights, MI 48071 248-291-1210 CONTACT: Rob Swadosh The Dilenschneider Group 212-922-0900 INFUSYSTEM HOLDINGS, INC. REPORTS THIRD QUARTER REVENUE OF $16.6 MILL
Read more →-INFU
Oct 30, 2014InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, Michigan 48071 248-291-1210 FOR IMMEDIATE RELEASE Thursday
Thursday, October 30, 2014 CONTACT: Rob Swadosh The Dilenschneider Group 212-922-0900 INFUSYSTEM HOLDINGS, INC. TO ISSUE THIRD QUARTER 2014 FINANCIAL RESULTS ON MONDAY, NOVEMBER 10, 2014 Investor Conference Call to be Held at 9:00 a.m. Eastern Time MADISON HEIGHTS, MI,
Read more →-INFU
Aug 1, 2014InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, MI 48071 FOR IMMEDIATE RELEASE 248-291-1210 Friday
InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, MI 48071 FOR IMMEDIATE RELEASE 248-291-1210 Friday, August 1, 2014 CONTACT: Rob Swadosh The Dilenschneider Group 212-922-0900 INFUSYSTEM HOLDINGS, INC. REPORTS SECOND QUARTER REVENUE OF $16.4 MI
Read more →-INFU
May 19, 2014InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, MI 48071 248-291-1210 FOR IMMEDIATE RELEASE Monday
Monday, May 19, 2014 CONTACT: Rob Swadosh The Dilenschneider Group 212-922-0900 INFUSYSTEM ANNOUNCES REDUCED INTEREST RATE ON EXISTING $36.5 MILLION CREDIT FACILITY WITH WELLS FARGO AND MADISON HEIGHTS, MICHIGAN, May 19, 2014 InfuSystem Holdings, Inc. (NYSE MKT: INFU) ( I
Read more →-INFU
May 16, 2014to the Company s current report on Form 8-K filed with the Securities and Exchange Commission on
Leading Supplier of Infusion Services A Letter from our CEO Since joining as CEO on April 1, 2013, I ve immensely enjoyed working with the InfuSystem team. My appreciation and thanks go out to each and every colleague. They embraced change enthusiastically, contributing many n
Read more →-INFU
May 9, 2014InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, MI 48071 248-291-1210 FOR IMMEDIATE RELEASE Friday
INFUSYSTEM HOLDINGS, INC. ANNOUNCES RESULTS OF 2014 ANNUAL MEETING OF STOCKHOLDERS MADISON HEIGHTS, MI, May 9, 2014 InfuSystem Holdings, Inc. (NYSE MKT: INFU), a leading national provider of infusion pumps and related services for the U.S. healthcare industry, announces the vo
Read more →-INFU
Apr 28, 2014InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, Michigan 48071 248-291-1210 FOR IMMEDIATE RELEASE Monday
Monday, April 28, 2014 INFUSYSTEM HOLDINGS, INC. TO ISSUE FIRST QUARTER 2014 FINANCIAL RESULTS ON MONDAY, MAY 5, 2014 Investor Conference Call to be Held at 9:00 a.m. Eastern Time MADISON HEIGHTS, MI, April 28, 2014 InfuSystem Holdings, Inc. (NYSE MKT: INFU), a leading nation
Read more →-INFU
Apr 23, 2014InfuSystem Holdings, Inc. FOR IMMEDIATE RELEASE Wednesday
InfuSystem Holdings, Inc. FOR IMMEDIATE RELEASE Wednesday, April 23, 2014 31700 Research Park Drive Madison Heights, MI 48071 248-291-1210 CONTACT: Rob Swadosh The Dilenschneider Group 212-922-0900 ISS RECOMMENDS VOTE FOR ALL INFUSYSTEM HOLDINGS, INC. ANNUAL MEET
Read more →-INFU
Apr 9, 2014InfuSystem Holdings, Inc. FOR IMMEDIATE RELEASE 31700 Research Park Drive Madison Heights, MI 48071 248-291-1210 Wednesday
InfuSystem Holdings, Inc. FOR IMMEDIATE RELEASE 31700 Research Park Drive Madison Heights, MI 48071 248-291-1210 Wednesday, April 9, 2014 INFUSYSTEM HOLDINGS, INC. NOMINATES GREGG O. LEHMAN, Ph.D. to BOARD OF DIRECTORS Current Directors Each to Stand for Re-election, Incl
Read more →-INFU
Jan 13, 2014InfuSystem Holdings, Inc. Sidoti& Company LLC Conference
Holdings, Inc. Sidoti& Company LLC Conference January 13, 2014 Eric K. Steen, CEO Jonathan P. Foster, CFO Harbor Statement Certain statements contained in this presentation are forward -looking statements and are based on future expectations, plans and prospects for InfuSystem H
Read more →-INFU
Jan 9, 2014InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, MI 48071 248-291-1210 FOR IMMEDIATE RELEASE Thursday
Thursday, January 9, 2014 INFUSYSTEM HOLDINGS, INC. TO PRESENT AT SIDOTI & COMPANY SEMI-ANNUAL MICROCAP CONFERENCE ON JANUARY 13, 2014 MADISON HEIGHTS, MICHIGAN, January 9, 2014 InfuSystem Holdings, Inc. (NYSE MKT: INFU) ( InfuSystem or the Company ), a leading national provi
Read more →-INFU
Dec 5, 2013Safe Harbor Statement Certain statements contained in this release are forward looking statements and are based on future expectations, plans and prospects for InfuSystem Holdings, Inc. s ( InfuSystem , INFU , the Compan
Eq., and Other Assets, net (4,611) $ (2,444) $ (4,502) $ (2,558) $ (791) $ (588) $ Acquisition of intangible assets (625) $ $ Cash paid for acquisition, net of cash acquired $ (16,616) $ NET CASH PROVIDED BY INVESTING ACTIVITIES (4,611) $ (19,060) $ (5,127) $ (2,558) $ (791) $ (5
Read more →-INFU
Nov 18, 2013InfuSystem Holdings, Inc. Shareholders Q3?13 Presentation
InfuSystem Holdings, Inc. Shareholders Q3?13 Presentation November 18, 2013 Eric K. Steen, CEO Jonathan P. Foster, CFO Infusystem Infusion made easy Safe Harbor Statement Certain statements contained in this release are forward?looking statements and are based on future expectat
Read more →-INFU
Aug 29, 2013InfuSystem Holdings, Inc. Post Shareholders Meeting
InfuSystem Holdings, Inc. Post Shareholders Meeting Jonathan P. Foster, CFO INFUSION MADE EASY SM Safe Harbor Statement contained in this release are forward-looking statements and are based on future expectations, plans and prospects for InfuSystem Holdings, Inc. s ( InfuSy
Read more →-INFU
Aug 13, 2013InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, MI 48071 248-291-1210 FOR IMMEDIATE RELEASE Tuesday
Tuesday, August 13, 2013 INFUSYSTEM HOLDINGS, INC. REPORTS PROFIT IN SECOND QUARTER 2013 Three and Six Month Results Show Year-to-Year Improvements HEIGHTS, MICHIGAN, August 13, 2013 InfuSystem Holdings, Inc. (NYSE MKT: INFU) ( InfuSystem or the Company ), a leading national
Read more →-INFU
Jul 17, 2013Ryan J. Morris rmorris@mesoncapital.com (607) 279 - 5382 www.mesoncapital.com
Special Committee of the Board of Directors InfuSystem Holdings, Inc. 31700 Research Park Drive Capital Partners LP and I are pleased to set forth our good faith indication of interest to acquire, through a newly-formed entity, InfuSystem Holdings, Inc. ( InfuSystem or the Com
Read more →-INFU
May 2, 2013InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, MI 48071 248-291-1210
HOLDINGS, INC. NAMES MIKE MCREYNOLDS CHIEF INFORMATION OFFICER MADISON HEIGHTS, MICHIGAN, May 2, 2013 InfuSystem Holdings, Inc. (NYSE MKT: INFU) ( InfuSystem or the Company ), a leading national provider of infusion pumps and related services for the U.S. healthcare industry,
Read more →-INFU
Mar 28, 2013InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, MI 48071 FOR IMMEDIATE RELEASE Thursday
InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, MI 48071 FOR IMMEDIATE RELEASE Thursday, March 28, 2013 248-291-1210 CONTACT: Rob Swadosh / Patrick Malone The Dilenschneider Group 212-922-0900 INFUSYSTEM HOLDINGS, INC. REPORTS HIGHER FOURTH
Read more →-INFU
Nov 14, 2012InfuSystem Holdings, Inc. Announces Third Quarter, Fiscal 2012 Results InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, MI 48071 248-291-1210 FOR IMMEDIATE RELEASE Wednesday
InfuSystem Holdings, Inc. Announces Third Quarter, Fiscal 2012 Results Wednesday, November 14, 2012 CONTACT: Rob Swadosh / Patrick Dilenschneider Group INFUSYSTEM HOLDINGS, INC. REPORTS THIRD QUARTER PROFIT; Company Further Improves Liquidity Position MADISON HEIGHTS, MICHI
Read more →-INFU
Nov 2, 2012InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, Michigan 48071 248-291-1210 FOR IMMEDIATE RELEASE Friday
InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, Michigan 48071 248-291-1210 Friday, November 2, 2012 CONTACT: Rob Swadosh / Gabrielle Gutscher The Dilenschneider Group 212-922-0900 INFUSYSTEM HOLDINGS, INC. TO ISSUE THIRD QUARTER 2012 FINANCI
Read more →-INFU
Aug 7, 2012InfuSystem Holdings, Inc. Announces Second Quarter, Fiscal 2012 Results InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, MI 48071 248-291-1210 INVESTOR CONTACT: Jonathan P. Foster Chief Financial Offi
InfuSystem Holdings, Inc. Announces Second Quarter, Fiscal 2012 Results Chief Financial Officer Tuesday, August 07, 2012 InfuSystem Holdings, Inc. Reports $14.1 Million of Revenues for the Second Quarter of 2012; Announces Annualized Cost Savings in Excess of $1 million MADI
Read more →-INFU
Jun 8, 2012InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, MI 48071 248-291-1210 INVESTOR CONTACT: Jonathan P. Foster Chief Financial Officer Info@InfuSystem.com 800-962-9656 FOR IMMEDIATE RELEASE Friday
Friday, June 8, 2012 INFUSYSTEM HOLDINGS, INC. TERMINATES MADISON HEIGHTS, MI, June 8, 2012 InfuSystem Holdings, Inc. (NYSE MKT: INFU), the leading national provider of infusion pumps and related services for the healthcare industry, said today it had formally amended the Comp
Read more →-INFU
May 21, 2012InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, MI 48071 248-291-1210 INVESTOR CONTACT: Jonathan P. Foster Chief Financial Officer Info@InfuSystem.com 800-962-9656 FOR IMMEDIATE RELEASE Monday
Chief Financial Officer Monday, May 21, 2012 InfuSystem Holdings, Inc. Reports $14.3 Million of Revenues and $1.6 Million of EBITDA for the First Quarter of 2012 MADISON HEIGHTS, MICHIGAN, May 21, 2012 InfuSystem Holdings, Inc. (NYSE MKT: INFU) ( InfuSystem or the Company ), t
Read more →-INFU
May 15, 2012INVESTOR CONTACT: Jonathan P. Foster Chief Financial Officer Info@InfuSystem.com 248-291-1210 InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, Michigan 48071 248-291-1210 FOR IMMEDIATE RELEASE Tuesday
Tuesday, May 15, 2012 Q1 EARNINGS CALL RELEASE: May 15 INFUSYSTEM HOLDINGS, INC. TO ANNOUNCE FIRST QUARTER 2012 FINANCIAL RESULTS ON MAY 21, 2012 MADISON HEIGHTS, MI. MAY 15, 2012 InfuSystem Holdings, Inc. (NYSE MKT; INFU), the leading national provider of infusion pumps and
Read more →-INFU
Apr 24, 2012InfuSystem Announces Agreement With Investor Group Regarding 2012 Annual Meeting of Stockholders InfuSystem Appoints Five New Directors to Board Dilip Singh Named Interim
InfuSystem Announces Agreement With Investor Group Regarding 2012 Annual Meeting of Stockholders InfuSystem Appoints Five New Directors to Board Dilip Singh Named Interim CEO MADISON HEIGHTS, Mich., April 24, 2012 /PRNewswire/ InfuSystem Holdings, Inc. (NYSE Amex: INFU) (the
Read more →-INFU
Mar 16, 2012INVESTOR CONTACT: Pat LaVecchia Vice Chairman Info@InfuSystem.com Tel: (800) 962-9656 MEDIA CONTACT: Andrew Siegel / Scott Bisang Joele Frank, Wilkinson Brimmer Katcher Tel: (212) 355-4449 FOR IMMEDIATE RELEASE INFUSYSTE
Joele Frank, Wilkinson Brimmer Katcher INFUSYSTEM APPOINTS JONATHAN FOSTER AS CHIEF FINANCIAL OFFICER League City, TX, Mar. 16, 2012 InfuSystem Holdings, Inc. (NYSE Amex: INFU) ( Company ), the leading national provider of infusion pumps and related services, today announced th
Read more →-INFU
Mar 15, 2012InfuSystem Holdings, Inc. 2450 South Shore Blvd., Suite 402 League City, Texas 77573 248-291-1210 INVESTOR CONTACT: Pat LaVecchia Vice Chairman Info@InfuSystem.com 800-962-9656 FOR IMMEDIATE RELEASE Thursday
Thursday, March 15, 2012 InfuSystem Holdings, Inc. Reports Fourth Quarter and Fiscal Year 2011 Earnings League City, TX, March 15, 2012 InfuSystem Holdings, Inc. (NYSE Amex: INFU), the leading provider of infusion pumps and related services, today reported results for the fourt
Read more →-INFU
Feb 6, 2012InfuSystem Holdings, Inc. 31700 Research Park Drive INVESTOR CONTACT: Madison Heights, MI 48071 Pat LaVecchia 248-291-1210 Vice Chairman Info@InfuSystem.com 800-962-9656 MEDIA CONTACT: David Haar Info@InfuSystem.com Tel:
InfuSystem Holdings, Inc. 31700 Research Park Drive INVESTOR CONTACT: Madison Heights, MI 48071 Pat LaVecchia 248-291-1210 Vice Chairman Info@InfuSystem.com 800-962-9656 Monday, February 6, 2012 InfuSystem Holdings, Inc. Announces Preliminary, Unaudited Quarter and F
Read more →-INFU
Nov 10, 2011InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, MI 48071 248-291-1210 INVESTOR CONTACT: Pat LaVecchia Vice Chairman Info@InfuSystem.com 800-962-9656 FOR IMMEDIATE RELEASE Thursday
InfuSystem Holdings, Inc. 31700 Research Park Drive Madison Heights, MI 48071 248-291-1210 Thursday, November 10, 2011 InfuSystem Holdings, Inc. Reports $14.5 Million of Revenues and $4.0 Million of Adjusted EBITDA for the Third Quarter of 2011. MADISON HEIGHTS, MICHIGAN
Read more →-INFU
Mar 10, 2011InfuSystem Holdings, Inc. 31700 Research Park Drive INVESTOR CONTACT: Madison Heights, MI 48071 Pat LaVecchia 248-291-1210 Vice Chairman Info@InfuSystem.com 800-962-9656 FOR IMMEDIATE RELEASE Thursday
InfuSystem Holdings, Inc. 31700 Research Park Drive INVESTOR CONTACT: Madison Heights, MI 48071 Pat LaVecchia 248-291-1210 Vice Chairman Info@InfuSystem.com 800-962-9656 Thursday, March 10, 2011 InfuSystem Holdings, Inc. Reports $13.1 Million of Reven
Read more →-INFU
Dec 10, 2010InfuSystem Holdings, Inc. (248) 291-1210 Investor Contacts: Asher Dewhurst Bob East Westwicke Partners Infusystem@westwicke.com Tel: (443) 213-0500 InfuSystem Announces Jim Froisland as Interim CFO
InfuSystem Holdings, Inc. Infusystem@westwicke.com InfuSystem Announces Jim Froisland as Interim CFO Madison Heights, Michigan December 10, 2010 InfuSystem Holdings, Inc. (OTCBB: INHI; INHIW; INHIU), the leading provider of infusion pumps and associated products and services,
Read more →-INFU
Jun 15, 2010Sean Whelan, CFO InfuSystem (248) 291-1210 Investor Contacts: Asher Dewhurst Bob East Westwicke Partners Infusystem@westwicke.com Tel: (443) 213-0500 InfuSystem Acquires First Biomedical, Inc. Madis
Infusystem@westwicke.com InfuSystem Acquires First Biomedical, Inc. Madison Heights, Michigan June 15, 2010 InfuSystem Holdings, Inc. (OTCBB: INHI; INHIW; INHIU), announced today that it has acquired First Biomedical, Inc. for total consideration of $17.2 million. First Biomed
Read more →Competitive Position
How INFU ranks across every disease it competes inCompetitive Position is a premium feature
See how INFU ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial